What Happens Before Renal Therapy Starts: Kidney Tests, Imaging and Nephrology Assessment

The letter arrives on a Tuesday. A routine blood test, ordered for something else entirely, has come back with a creatinine reading the family doctor wants “a specialist to look at.” There is a referral, a date some weeks away, and a long stretch of evenings spent typing words like eGFR into a search bar. For most people, this is how a nephrology assessment before treatment begins: not with a crisis, but with a number that nobody has yet explained.

What follows is rarely a single appointment. Kidney specialists work more like detectives than mechanics. They want to know how much filtering capacity remains, how quickly it is changing, and, above all, why. Those three questions take time, repeat samples, and often a scan or two.

This article walks through that process in the order most patients experience it, from the first blood draw to the conversation about whether any renal therapy is needed at all, and if so, which kind and when.

Why a nephrology assessment before treatment takes weeks, not a single visit

Kidney function is measured, not seen. A single blood test captures one moment, and that moment can be skewed by things that have nothing to do with kidney disease: a hot day with too little to drink, a large steak the night before, a course of anti-inflammatory painkillers, or simply having more muscle than average. Creatinine, the waste product doctors track most closely, is made by muscle and cleared by the kidneys, so a marathon runner and a frail older adult can have very different “normal” values.

That is why the definition of chronic kidney disease (CKD) builds in time. The NHS and the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) both describe CKD as an estimated glomerular filtration rate (eGFR) below 60, or evidence of kidney damage such as protein in the urine, that persists for at least three months. One low reading is a prompt to look again; it is not a diagnosis.

The assessment is really trying to answer three questions in sequence. How much function is left? How fast is it changing? And what is causing it? The first two come from repeated blood and urine tests. The third may need imaging, a review of every medicine and supplement in the house, and occasionally a biopsy.

Sometimes the answer to the third question changes everything. A blocked urinary tract, an untreated infection, or a medicine that is stressing the kidneys can all produce alarming numbers that improve once the cause is addressed. Nephrologists are trained to distinguish an acute kidney injury, which can recover over days to weeks, from chronic scarring, which generally does not. Rushing to the word “therapy” before that distinction is made would serve nobody.

What actually happens at the first nephrology appointment

Expect a longer conversation than most medical visits. The nephrologist will want the full story: when the abnormal result first appeared, whether older results exist for comparison, and whether anything has changed in your urine, your weight, your energy, or your sleep. Diabetes and high blood pressure account for most CKD in the United States, according to the NIDDK, so both will be explored in detail, along with family history. Some kidney conditions, such as polycystic kidney disease, run in families.

Medicines get particular attention. Bring every bottle, or a photographed list, including over-the-counter painkillers, antacids, herbal products and protein or creatine supplements. Several common products are cleared by the kidneys or can affect their blood flow; the specialist is not there to judge, only to build an accurate picture.

The physical examination is quieter than people expect. Blood pressure is measured carefully, sometimes in both arms and after sitting. The doctor checks for fluid in the ankles or around the lungs, listens to the heart, feels the abdomen, and may look at the skin and nails. None of this diagnoses kidney disease on its own, but it helps stage how much the body is being affected.

The visit usually ends with a plan rather than a verdict: a set of blood and urine tests, often a kidney ultrasound, and a follow-up date. If your referral letter already includes recent labs, some of this may be ordered in advance so the second visit can focus on results. Writing your questions down beforehand, and bringing someone to listen alongside you, makes that second conversation far more useful.

Kidney function tests explained: what the blood work measures

The blood panel a nephrologist orders is broader than the one that triggered the referral. Each item answers a different question about what the kidneys are, or are no longer, doing.

Creatinine is the headline measure. Because muscle produces it at a fairly steady rate, a rising level suggests the kidneys are clearing less. Blood urea nitrogen (BUN) tracks another waste product; it climbs with reduced filtration but also with dehydration or a high-protein diet, which is why it is read alongside creatinine rather than alone. Cystatin C, a protein made by nearly all cells, is sometimes added because it is less influenced by muscle mass, which matters for people who are very muscular, very slight, or have lost weight through illness.

Electrolytes reveal how well the kidneys are balancing body chemistry. Potassium can rise dangerously when filtering falls, affecting heart rhythm. Bicarbonate drops when the kidneys can no longer remove acid. Sodium reflects water balance. Calcium, phosphate and parathyroid hormone (PTH) show whether bone and mineral metabolism has started to shift, a change the NIDDK notes can begin well before dialysis is discussed.

A complete blood count checks for anemia. Healthy kidneys make erythropoietin, the hormone that tells bone marrow to produce red cells, so a low hemoglobin can be an early kidney signal. Blood sugar (HbA1c) and cholesterol are included because diabetes and cardiovascular disease travel closely with kidney disease. Depending on the suspected cause, the specialist may also request immune tests, such as antibodies associated with lupus or vasculitis, and viral screens for hepatitis B, hepatitis C and HIV, all of which can affect the kidneys and also shape later treatment choices.

eGFR and creatinine meaning: reading the numbers on your report

The estimated glomerular filtration rate, or eGFR, is a calculation, not a direct measurement. It uses your creatinine (or cystatin C), age and sex to estimate how many milliliters of blood the kidneys filter each minute, adjusted to a standard body size. MedlinePlus describes a result of 90 or above as generally normal, while the NIDDK stages CKD as follows once the finding persists for three months:

• eGFR 60–89 with signs of kidney damage: mildly reduced function
• eGFR 45–59: mild to moderate reduction
• eGFR 30–44: moderate to severe reduction
• eGFR 15–29: severe reduction
• eGFR below 15: kidney failure

Two cautions keep these numbers honest. First, eGFR is an estimate with a margin of error, so a change from 52 to 48 between two tests may mean nothing at all; a steady downward slope across several results means much more. Second, the formula assumes an average body. Pregnancy, amputation, extreme athleticism, malnutrition and certain medicines can push the estimate up or down without any real change in the kidneys. That is precisely when cystatin C, or a timed urine collection, earns its place.

Patients often ask which number matters most: the eGFR or the creatinine. In practice the eGFR is easier to interpret because it already accounts for age and sex, but clinicians look at both, together with urine albumin, because two people with the same eGFR can carry very different risks. A result on a laboratory printout is a data point. Its meaning comes from the trend and the context your team places around it.

What the urine tells a kidney specialist that blood cannot

Blood tests show how much the kidneys are filtering. Urine tests show whether the filters themselves are leaking, and that distinction is central to the nephrology assessment before treatment. The tiny filtering units, called glomeruli, are designed to hold back protein and blood cells. When they are damaged, albumin (the main blood protein) slips through, often years before eGFR starts to fall.

The key test is the urine albumin-to-creatinine ratio, or uACR. Measuring albumin against creatinine in the same sample corrects for how dilute or concentrated the urine happens to be, so a single first-morning sample is usually enough. The NIDDK lists a ratio above 30 as abnormal, and higher categories carry higher risk of both kidney progression and cardiovascular events. This is why modern CKD staging combines eGFR with albuminuria: two people at the same eGFR can be in quite different risk bands depending on their urine.

A dipstick and microscopy add detail. Blood in the urine, particularly when the red cells look misshapen under the microscope or are clumped into casts, points toward inflammation in the glomeruli rather than a bladder or stone problem. Certain crystals hint at stone-forming tendencies. White cells suggest infection or, less commonly, inflammation of the kidney tissue itself.

Occasionally the specialist asks for a 24-hour collection, where all urine over a full day is saved in a container. It is inconvenient but useful when protein loss is heavy or when the eGFR estimate is unreliable. If you are asked to do one, timing matters: start the clock after discarding the first morning void and include the first void of the following morning. Exercise, fever and menstruation can all alter results, so mention them to the team.

Which imaging scans are used before renal therapy, and why

Ultrasound is almost always first. It uses sound waves rather than radiation, takes a few minutes per kidney, and answers questions blood tests cannot. Are both kidneys present and of normal size? Small, shrunken kidneys with a thin outer layer suggest long-standing scarring. Enlarged kidneys full of cysts suggest an inherited condition. A swollen collecting system, called hydronephrosis, means urine is backing up behind a blockage, which may be treatable. The bladder is often checked as well, because incomplete emptying can quietly strain the kidneys.

Doppler ultrasound adds a picture of blood flow. It is used when the team suspects narrowing of a renal artery, which can drive high blood pressure and reduce function on one side.

Computed tomography (CT) offers sharper anatomy and is the standard test for kidney stones. Magnetic resonance imaging (MRI) gives detailed soft-tissue images without X-rays. Both can be performed with or without contrast agents, and here the kidneys themselves become a consideration. Iodinated CT contrast and gadolinium MRI contrast are cleared by the kidneys, and both carry specific cautions when eGFR is low. The Mayo Clinic notes that clinicians weigh the diagnostic benefit against these risks and often choose non-contrast protocols in people with reduced function. Expect to be asked about your latest eGFR before any contrast scan.

Nuclear medicine scans have a narrower role. By tracking a small dose of a radioactive tracer, they show how much each kidney contributes to total function and whether drainage is obstructed, information that matters when surgery on one kidney is being considered.

None of these scans grades function as precisely as a blood test, and none replaces the urine work-up. Imaging explains structure; the laboratory explains performance. Together they narrow the list of causes and help decide whether a biopsy is worth its small risk.

Kidney biopsy: what to expect if one is recommended

Most people going through a nephrology assessment never need a biopsy. It is reserved for situations where the cause remains unclear after blood, urine and imaging, and where knowing the exact diagnosis would change treatment: heavy protein loss, blood and protein together, a rapid unexplained decline, or suspected inflammatory disease such as lupus nephritis or vasculitis. It is also used to monitor transplanted kidneys.

The procedure itself is brief. According to the Mayo Clinic, it is usually done as an outpatient using local anesthetic. You lie on your stomach (or on your back if you have a transplant), the radiologist or nephrologist locates the kidney with ultrasound, numbs the skin and deeper tissue, and passes a thin needle to take two or three small cores while you hold your breath for a few seconds. The sampling takes minutes; the preparation and positioning take longer.

Recovery is about lying still. The Mayo Clinic describes several hours of bed rest on your back afterward, with blood pressure and urine checked for bleeding, and advises avoiding heavy lifting or strenuous exercise for about two weeks. A small amount of blood in the urine during the first day is common. Results typically arrive within about a week, though special stains and electron microscopy can take longer.

The main risk is bleeding. Minor bleeding is frequent and self-limiting; bleeding severe enough to need a transfusion or a procedure to stop it is uncommon, and the team will discuss your individual risk. Blood pressure is controlled beforehand, and medicines that affect clotting are reviewed. If you take a blood thinner or aspirin, do not stop it on your own; the prescribing clinician and the biopsy team will decide together whether and how it should be paused.

Who is usually offered renal therapy now, and who is asked to wait

Renal replacement therapy, meaning dialysis or transplantation, becomes a live discussion when kidney function nears the failure range. The NIDDK places that range at an eGFR below 15. But the number alone does not decide the start date. Two people at an eGFR of 12 can feel completely different, and nephrologists increasingly start treatment based on how the person is doing rather than on a threshold crossed on paper.

Signs that tend to move the decision forward include fluid that cannot be controlled with adjustments to diet and medicines, potassium or acid levels that keep drifting into dangerous territory, and the cluster of symptoms called uremia: persistent nausea, loss of appetite, metallic taste, itching, poor sleep and difficulty concentrating. Weight loss from not eating is taken seriously, because nutrition affects everything that follows.

Many people are, quite reasonably, asked to wait. Someone with a stable eGFR in the 20s, no symptoms and well-managed blood pressure may be monitored for years. Someone whose decline is driven by a reversible cause, such as an obstruction or a medicine that has since been changed, is given time to see whether function recovers; acute kidney injury can improve over weeks. Someone with heavy protein loss from an inflammatory disease may be treated for that disease first, with dialysis held in reserve.

Waiting is not the same as doing nothing. It is the period when a transplant work-up can begin so that, if kidney failure arrives, a pre-emptive transplant is possible. It is also when dialysis access can be created, education completed, and vaccinations updated. For frail or very elderly people, or those with other serious illness, conservative kidney management, which treats symptoms without dialysis, is a recognized pathway the NHS describes as a legitimate choice, not a failure to treat. Age by itself does not exclude anyone from any option; overall health does the deciding.

How the nephrology assessment before treatment shapes the choice of therapy

By the time options are on the table, the assessment has done more than confirm a diagnosis. It has mapped the heart, the blood vessels, the abdomen, the immune system and the person’s daily life, because each therapy asks something different of each of them. The table below summarizes what the team is looking at and the typical lead times, drawn from NIDDK patient guidance.

Option	What the assessment focuses on	Typical preparation lead time
In-center hemodialysis	Heart function, blood pressure stability, vein quality in the arms, ability to travel three times a week	Fistula needs about 2–3 months to mature; graft about 2–3 weeks (NIDDK)
Home hemodialysis	Same vascular checks plus home space, a trained partner or self-care ability, and training time	Same access timelines plus several weeks of training (NIDDK)
Peritoneal dialysis	Abdominal surgery history, hernias, body size, ability to perform sterile exchanges, home storage	Catheter placed surgically; healing period before regular use (NIDDK)
Kidney transplant	Cancer screening, heart and vascular fitness, infection screening, tissue typing, living-donor availability	Evaluation often runs alongside CKD monitoring; waiting varies widely (NIDDK)
Conservative kidney management	Symptom burden, frailty, goals of care, family and community support	No procedure; planning begins whenever the person chooses (NHS)

Notice how many items in the middle column are not kidney tests at all. An echocardiogram, a hernia examination or a conversation about who is at home can be as decisive as any eGFR. This is the moment the assessment stops being about a diagnosis and becomes about a person. The treating team lays out the trade-offs; the choice, and its timing, belongs to the patient and that team together.

Preparing for dialysis access: the timeline most people don't expect

If hemodialysis is a likely destination, the single most time-sensitive step in the whole assessment is planning access: the connection between the bloodstream and the dialysis machine. It is also the step people most often hear about too late.

The preferred option is an arteriovenous fistula, created by a surgeon joining an artery to a vein, usually in the forearm or upper arm. Over the following weeks the vein thickens and enlarges under arterial pressure until it can be needled repeatedly. The NIDDK gives a maturation time of about two to three months, and some fistulas need a second procedure or never mature at all, which is why surgeons like to start early. A synthetic graft, a soft tube joining artery and vein, can be used sooner, typically within two to three weeks according to the NIDDK, but is more prone to clotting and infection over time. A catheter placed in a large neck vein works immediately and is reserved for urgent starts because infection risk is higher.

Before any surgery, a vascular ultrasound maps the arteries and veins of both arms to find the best site. From that point on, one arm is usually designated for future access and protected: no blood draws, no blood pressure cuffs, no intravenous lines on that side. Ask which arm, and tell every clinician you meet.

For peritoneal dialysis, a soft catheter is placed through the abdominal wall in a short operation, and the surrounding tissue needs time to heal before the catheter is used routinely. Training in sterile technique follows.

Many people find this stage emotionally harder than the tests. Having a fistula created can feel like admitting that dialysis is coming. Nephrologists frame it differently: a matured fistula that is never needed is a minor inconvenience, whereas an emergency catheter start is a genuinely worse experience. Preparation buys options.

What the following weeks usually look like

Once the first round of results is back, the pace settles into a rhythm that can feel slow but is doing important work. Blood and urine tests are repeated, often at intervals of several weeks to a few months, to establish whether the eGFR is stable, drifting or falling steeply. The three-month window that both the NHS and NIDDK use to confirm chronic kidney disease is the minimum; where the picture is uncertain, the team may want two or three more points on the graph before drawing conclusions.

Medicines are reviewed with the prescribing clinician. Some are adjusted because the kidneys clear them more slowly; others may be paused or replaced. This is a conversation to have with the person who wrote the prescription, not a change to make at home. Blood pressure control is tightened where needed, since the NIDDK identifies it as one of the strongest levers on progression.

Other members of the team appear. A renal dietitian talks through protein, salt, potassium and phosphate in the context of your own results rather than generic lists. A nurse educator explains the different therapies, often with models and videos. A social worker or care coordinator discusses work, transport, insurance paperwork and who supports you at home. Where dialysis is likely, hepatitis B vaccination and other immunizations may be recommended, since the CDC notes that people receiving dialysis are at higher risk of bloodborne infections.

Somewhere in these weeks, most people start keeping a simple record: weight each morning, blood pressure readings, how much they are drinking and passing, and any new symptoms. It sounds mundane. It is often the single most useful thing a patient brings to the next appointment, because it turns vague impressions into data the team can act on.

What people often get wrong about kidney tests and the specialist visit

The most common misunderstanding is that one abnormal creatinine means dialysis is near. It almost never does. A single result is a prompt to repeat the test under better conditions; chronic disease is defined by persistence over three months, and even confirmed CKD progresses slowly in most people, according to the NIDDK.

The second is the mirror image: feeling well must mean the kidneys are fine. Kidneys have enormous reserve, and symptoms often appear only when function is severely reduced. This is exactly why the assessment leans on laboratory tests rather than how someone feels, and why protein in the urine is treated seriously even when everything else looks normal.

Third, drinking large volumes of water does not repair damaged kidneys. Staying normally hydrated helps avoid the temporary dips that confuse test results, but excess fluid can be harmful once the kidneys struggle to excrete it. Your team will tell you if your intake should change.

Fourth, a biopsy is not routine. Most assessments end without one; it is reserved for cases where the result would change management.

Fifth, “natural” does not mean kidney-safe. The NIH Office of Dietary Supplements notes that some herbal and dietary supplements have been linked to kidney harm and can interact with prescribed medicines. Disclose everything you take.

Sixth, kidney disease is rarely painful. Back or flank pain is more often muscular, or related to stones or infection, than to CKD itself. Its absence is reassuring about nothing, and its presence points elsewhere.

Finally, dialysis is not the only ending. Pre-emptive transplant, home therapies and conservative management are all real pathways, and the purpose of the assessment is to find the one that fits.

Questions to ask your care team

Good questions do more than gather facts; they signal to the team what matters to you, which changes the conversation. Some people want every number explained. Others want to know how the process fits around a job or a grandchild’s school run. Both are legitimate agendas, and it helps to say which one you are bringing.

Questions that patients report finding most useful include:

• What is my current eGFR and urine albumin ratio, and how have they changed since the last test?
• Do you know yet what is causing my kidney problem, and what tests will help you find out?
• Is any part of this potentially reversible, and how long should we wait to see?
• Which of my medicines or supplements need reviewing with the person who prescribed them?
• Do I need a biopsy, and if so, what specifically would it change about my treatment?
• If my kidneys keep declining, roughly what timeframe are you expecting, and what would make you recommend starting therapy?
• Am I a candidate for a pre-emptive transplant evaluation, and when should that begin?
• If dialysis is likely, which arm should I protect, and when should access surgery be considered?
• Who on the team can I contact between visits, and what symptoms should trigger a call?
• What will my next appointment cover, and what should I bring?

Ask for written or printed copies of your results, and for the name of the person coordinating your care. If English is not your first language, request an interpreter; most health systems provide one. And if an answer does not make sense, say so in the room. Nephrology is full of estimates and probabilities, and a good clinician would rather explain a number twice than have you leave misunderstanding it.

When to call your doctor

Most of the assessment unfolds at a measured pace, but a few situations should not wait for the next scheduled visit. The MedlinePlus and NHS guidance on kidney disease, together with post-biopsy advice from the Mayo Clinic, point to the following.

Call emergency services or go to an emergency department if you develop chest pain, sudden severe shortness of breath, an irregular or very slow heartbeat, fainting, new confusion or drowsiness, or seizures. In someone with reduced kidney function these can signal dangerous potassium levels or fluid on the lungs, both of which need urgent treatment.

Contact your kidney team or doctor the same day if you notice a marked drop in how much urine you pass, rapid weight gain with swelling of the legs or face, vomiting that stops you keeping fluids down, a fever, or blood in the urine that is new, heavy or contains clots. After a kidney biopsy, the Mayo Clinic advises reporting bright red blood or clots in the urine beyond the first day, inability to pass urine, worsening pain at the biopsy site, dizziness or a fever.

Also let the team know promptly if you start any new medicine from another clinician, if you become pregnant or are planning to, or if you have been unwell with vomiting or diarrhea for more than a day, since dehydration can cause a sharp, sometimes reversible, fall in function.

This list is not a self-diagnosis tool. It is a set of signals that your treating team would want to hear about. When in doubt, call; the people who have spent weeks assessing your kidneys would far rather answer an unnecessary question than miss a necessary one.

Frequently asked questions

What does a nephrologist check at the first appointment?

A nephrologist reviews your kidney blood and urine results, blood pressure, medicines and supplements, family history, and risk factors such as diabetes. The examination looks for fluid retention, heart and lung signs and skin changes. Most first visits end with further tests ordered, commonly a repeat kidney panel, a urine albumin ratio and an ultrasound, rather than an immediate diagnosis.

How long does a nephrology assessment before treatment usually take?

Several weeks to a few months is typical, because chronic kidney disease is confirmed only when abnormal results persist for at least three months according to NHS and NIDDK guidance. Faster decisions are made when function is falling rapidly or symptoms are severe. Where dialysis access or transplant evaluation is needed, planning often runs in parallel with the diagnostic tests.

Can a high creatinine level go back to normal?

Sometimes, yes. Dehydration, certain medicines, urinary blockage and acute illness can all raise creatinine temporarily, and levels may return to baseline once the cause is addressed. Chronic scarring, by contrast, does not usually reverse. Distinguishing between the two is a central purpose of repeat testing, and your team will look at the trend over weeks rather than any one value.

Is a kidney biopsy always needed before starting dialysis?

No. Most people never need a biopsy. It is recommended when the cause of kidney disease is unclear after blood tests, urine tests and imaging, and when the answer would change treatment, for example if an inflammatory condition is suspected. When kidneys are already small and scarred on ultrasound, a biopsy often adds little and carries bleeding risk, so it is usually not performed.

What eGFR level means dialysis has to start?

There is no single number. The NIDDK defines kidney failure as an eGFR below 15, but the decision to begin dialysis rests on symptoms, fluid balance, potassium and acid levels and overall health rather than the value alone. Some people with an eGFR below 15 are monitored for a time; others start earlier because of complications. The treating team makes that call with the patient.

Why do I need a urine test if my blood tests already show kidney disease?

Blood tests measure how much the kidneys filter; urine tests show whether the filters are leaking protein or blood, which indicates active damage and predicts progression and heart risk. The albumin-to-creatinine ratio is also part of formal CKD staging. Microscopy of the urine can point toward specific causes, such as inflammation of the glomeruli, that blood tests cannot identify.

Are contrast scans safe if my kidneys are not working well?

They can be, but the decision is individual. Both iodinated CT contrast and gadolinium MRI contrast are cleared by the kidneys, and clinicians weigh the diagnostic benefit against the risks at your current eGFR. Non-contrast protocols are often chosen when function is reduced. Always tell the imaging team your latest kidney results and whether you are on dialysis.

Should I stop taking my medicines before seeing the kidney specialist?

No. Do not stop or change any prescribed medicine on your own. Bring a complete list, including over-the-counter painkillers and supplements, so the nephrologist can review it. If a medicine needs adjusting because of your kidney function, the prescribing clinician and the kidney team will agree the change together and tell you exactly what to do.

What is the difference between acute kidney injury and chronic kidney disease?

Acute kidney injury is a sudden fall in function over hours to days, often from dehydration, infection, blockage or a medicine, and it frequently recovers. Chronic kidney disease is reduced function or kidney damage lasting at least three months, usually from long-term conditions such as diabetes or high blood pressure. The assessment aims to tell them apart, because their outlook and management differ.

Can I be evaluated for a transplant before I ever start dialysis?

Yes. A pre-emptive transplant, performed before dialysis begins, is an established option, and referral for evaluation commonly starts once kidney function falls into the severely reduced range. The work-up includes heart, vascular, cancer and infection screening plus tissue typing, and can take months. Whether it is suitable depends on your overall health, which is exactly what the assessment maps out.

References

• Chronic kidney disease: Diagnosis (NHS)
• Tests & Diagnosis for Chronic Kidney Disease (NIH NIDDK)
• Glomerular Filtration Rate (GFR) Test (MedlinePlus)
• Hemodialysis (NIH NIDDK)

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.